Published in J Acquir Immune Defic Syndr on June 01, 2016
A Prospective Field Study: Introducing the Shang Ring in Routine Clinical Settings | NCT01567436
VMMC Devices-Introducing a New Innovation to a Public Health Intervention. J Acquir Immune Defic Syndr (2016) 0.75
Voluntary medical male circumcision: modeling the impact and cost of expanding male circumcision for HIV prevention in eastern and southern Africa. PLoS Med (2011) 7.56
Circumcision in HIV-infected men and its effect on HIV transmission to female partners in Rakai, Uganda: a randomised controlled trial. Lancet (2009) 6.80
Acceptability of male circumcision for prevention of HIV/AIDS in sub-Saharan Africa: a review. AIDS Behav (2006) 5.86
The effectiveness of male circumcision for HIV prevention and effects on risk behaviors in a posttrial follow-up study. AIDS (2012) 2.92
The safety of adult male circumcision in HIV-infected and uninfected men in Rakai, Uganda. PLoS Med (2008) 2.79
Acceptability of medical male circumcision among uncircumcised men in Kenya one year after the launch of the national male circumcision program. PLoS One (2011) 2.79
Voluntary medical male circumcision: an introduction to the cost, impact, and challenges of accelerated scaling up. PLoS Med (2011) 2.37
HIV prevention: male circumcision comparison between a nonsurgical device to a surgical technique in resource-limited settings: a prospective, randomized, nonmasked trial. J Acquir Immune Defic Syndr (2012) 2.34
Achieving the HIV prevention impact of voluntary medical male circumcision: lessons and challenges for managing programs. PLoS Med (2014) 2.26
Male circumcision and risk of HIV infection in women: a systematic review and meta-analysis. Lancet Infect Dis (2009) 1.99
The Shang Ring device for adult male circumcision: a proof of concept study in Kenya. J Acquir Immune Defic Syndr (2011) 1.80
Association of the ANRS-12126 male circumcision project with HIV levels among men in a South African township: evaluation of effectiveness using cross-sectional surveys. PLoS Med (2013) 1.78
Factors associated with the early resumption of sexual activity following medical male circumcision in Nyanza province, Kenya. AIDS Behav (2012) 1.73
Safety, effectiveness and acceptability of the PrePex device for adult male circumcision in Kenya. PLoS One (2014) 1.57
Sex with stitches: assessing the resumption of sexual activity during the postcircumcision wound-healing period. AIDS (2012) 1.54
The safety and acceptance of the PrePex device for non-surgical adult male circumcision in Rakai, Uganda. A non-randomized observational study. PLoS One (2014) 1.54
The long-term efficacy of medical male circumcision against HIV acquisition. AIDS (2013) 1.53
Does sex in the early period after circumcision increase HIV-seroconversion risk? Pooled analysis of adult male circumcision clinical trials. AIDS (2009) 1.48
"When I was circumcised I was taught certain things": risk compensation and protective sexual behavior among circumcised men in Kisumu, Kenya. PLoS One (2010) 1.45
Risk compensation following male circumcision: results from a two-year prospective cohort study of recently circumcised and uncircumcised men in Nyanza Province, Kenya. AIDS Behav (2014) 1.43
Identifying and addressing barriers to uptake of voluntary medical male circumcision in Nyanza, Kenya among men 18-35: a qualitative study. PLoS One (2014) 1.33
Randomized controlled trial of the shang ring versus conventional surgical techniques for adult male circumcision: safety and acceptability. J Acquir Immune Defic Syndr (2014) 1.31
Male circumcision in the general population of Kisumu, Kenya: beliefs about protection, risk behaviors, HIV, and STIs. PLoS One (2010) 1.30
Factors associated with the safety of voluntary medical male circumcision in Nyanza province, Kenya. Bull World Health Organ (2012) 1.25
Women's roles in voluntary medical male circumcision in Nyanza Province, Kenya. PLoS One (2012) 1.22
Time to complete wound healing in HIV-positive and HIV-negative men following medical male circumcision in Kisumu, Kenya: a prospective cohort study. PLoS One (2013) 1.08
Field study of adult male circumcision using the ShangRing in routine clinical settings in Kenya and Zambia. J Acquir Immune Defic Syndr (2014) 1.07
The ShangRing device for simplified adult circumcision. Nat Rev Urol (2010) 1.07
[A recommendable standard protocol of adult male circumcision with the Chinese Shang Ring: outcomes of 328 cases in China]. Zhonghua Nan Ke Xue (2009) 1.06
Factors associated with resumption of sex before complete wound healing in circumcised HIV-positive and HIV-negative men in Kisumu, Kenya. J Acquir Immune Defic Syndr (2013) 1.03
Changes in plasma viral load and penile viral shedding after circumcision among HIV-positive men in Kisumu, Kenya. J Acquir Immune Defic Syndr (2013) 0.99
A systematic review and meta-analysis of circumcision with Shang Ring vs conventional circumcision. Urology (2015) 0.97
Effect of text messaging to deter early resumption of sexual activity after male circumcision for HIV prevention: a randomized controlled trial. J Acquir Immune Defic Syndr (2014) 0.96
Understanding partial protection and HIV risk and behavior following voluntary medical male circumcision rollout in Kenya. Health Educ Res (2013) 0.88
Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet (2007) 38.98
Preexposure prophylaxis for HIV infection among African women. N Engl J Med (2012) 15.28
Varicocelectomy is associated with increases in serum testosterone independent of clinical grade. Urology (2013) 3.45
Acceptability of medical male circumcision among uncircumcised men in Kenya one year after the launch of the national male circumcision program. PLoS One (2011) 2.79
Adult male circumcision: results of a standardized procedure in Kisumu District, Kenya. BJU Int (2005) 2.51
Invited commentary: condom effectiveness-will prostate-specific antigen shed new light on this perplexing problem? Am J Epidemiol (2003) 2.45
Risk compensation is not associated with male circumcision in Kisumu, Kenya: a multi-faceted assessment of men enrolled in a randomized controlled trial. PLoS One (2008) 2.43
Herniorrhaphy with polypropylene mesh causing inguinal vasal obstruction: a preventable cause of obstructive azoospermia. Ann Surg (2005) 2.35
Voluntary medical male circumcision: translating research into the rapid expansion of services in Kenya, 2008-2011. PLoS Med (2011) 2.31
Adult male circumcision: effects on sexual function and sexual satisfaction in Kisumu, Kenya. J Sex Med (2008) 2.23
No-needle jet anesthetic technique for no-scalpel vasectomy. J Urol (2005) 2.12
The female condom: is "just as good" good enough? Sex Transm Dis (2003) 2.12
HIV-1 target cells in foreskins of African men with varying histories of sexually transmitted infections. Am J Clin Pathol (2006) 2.10
A nested case-control study of sexual practices and risk factors for prevalent HIV-1 infection among young men in Kisumu, Kenya. Sex Transm Dis (2007) 2.01
Adult male circumcision outcomes: experience in a developing country setting. Urol Int (2007) 2.00
Common variants at 9p21 and 8q22 are associated with increased susceptibility to optic nerve degeneration in glaucoma. PLoS Genet (2012) 2.00
The Shang Ring device for adult male circumcision: a proof of concept study in Kenya. J Acquir Immune Defic Syndr (2011) 1.80
The acceptability and safety of the Shang Ring for adult male circumcision in Rakai, Uganda. J Acquir Immune Defic Syndr (2013) 1.74
Factors associated with the early resumption of sexual activity following medical male circumcision in Nyanza province, Kenya. AIDS Behav (2012) 1.73
Increased incidence of testicular cancer in men presenting with infertility and abnormal semen analysis. J Urol (2005) 1.72
Microsurgical vasoepididymostomy: a prospective randomized study of 3 intussusception techniques in rats. J Urol (2003) 1.69
Intraoperative varicocele anatomy: a microscopic study of the inguinal versus subinguinal approach. J Urol (2003) 1.67
Stage-specific impact of tumor location on oncologic outcomes in patients with upper and lower tract urothelial carcinoma following radical surgery. Eur Urol (2012) 1.65
HPV vaccine acceptability among Kenyan women. Vaccine (2010) 1.65
Implementing voluntary medical male circumcision for HIV prevention in Nyanza Province, Kenya: lessons learned during the first year. PLoS One (2011) 1.61
No-scalpel, no-needle vasectomy. Urology (2006) 1.58
Value of serum antisperm antibodies in diagnosing obstructive azoospermia. J Urol (2008) 1.58
Superior outcomes of microsurgical vasectomy reversal in men with the same female partners. Fertil Steril (2004) 1.57
Aqueous humor dynamics: a review. Open Ophthalmol J (2010) 1.55
The long-term efficacy of medical male circumcision against HIV acquisition. AIDS (2013) 1.53
The impact of obstructive interval and sperm granuloma on outcome of vasectomy reversal. J Urol (2004) 1.52
The Spear and Shield intervention to increase the availability and acceptability of voluntary medical male circumcision in Zambia: a cluster randomised controlled trial. Lancet HIV (2015) 1.49
Impact of peri-operative blood transfusion on the outcomes of patients undergoing radical cystectomy for urothelial carcinoma of the bladder. BJU Int (2014) 1.49
Does sex in the early period after circumcision increase HIV-seroconversion risk? Pooled analysis of adult male circumcision clinical trials. AIDS (2009) 1.48
Concordance of near infrared spectroscopy with pressure flow studies in men with lower urinary tract symptoms. J Urol (2010) 1.48
Trends and inequalities in the surgical management of ureteric calculi in the USA. BJU Int (2013) 1.47
Glaucoma drainage implants: a critical comparison of types. Curr Opin Ophthalmol (2006) 1.47
International variation in artificial urinary sphincter use. Urology (2012) 1.46
Circumcision status and incident herpes simplex virus type 2 infection, genital ulcer disease, and HIV infection. AIDS (2012) 1.44
Randomized trial of the Shang Ring for adult male circumcision with removal at one to three weeks: delayed removal leads to detachment. J Acquir Immune Defic Syndr (2012) 1.43
Risk compensation following male circumcision: results from a two-year prospective cohort study of recently circumcised and uncircumcised men in Nyanza Province, Kenya. AIDS Behav (2014) 1.43
Adult male circumcision does not reduce the risk of incident Neisseria gonorrhoeae, Chlamydia trachomatis, or Trichomonas vaginalis infection: results from a randomized, controlled trial in Kenya. J Infect Dis (2009) 1.42
Increased risk of HIV acquisition among Kenyan men with human papillomavirus infection. J Infect Dis (2010) 1.41
In-center nocturnal hemodialysis: another option in the management of chronic kidney disease. Clin J Am Soc Nephrol (2009) 1.39
A lifetime cancer bioassay of quinacrine administered into the uterine horns of female rats. Regul Toxicol Pharmacol (2009) 1.39
Success of testicular sperm extraction [corrected] and intracytoplasmic sperm injection in men with Klinefelter syndrome. J Clin Endocrinol Metab (2005) 1.38
FEM-PrEP: adherence patterns and factors associated with adherence to a daily oral study product for pre-exposure prophylaxis. J Acquir Immune Defic Syndr (2014) 1.36
Factors associated with uptake of infant male circumcision for HIV prevention in western Kenya. Pediatrics (2012) 1.35
Randomized controlled trial of the shang ring versus conventional surgical techniques for adult male circumcision: safety and acceptability. J Acquir Immune Defic Syndr (2014) 1.31
Varicocele as a risk factor for androgen deficiency and effect of repair. BJU Int (2011) 1.29
Human papillomavirus detection by penile site in young men from Kenya. Sex Transm Dis (2007) 1.28
Vasectomy: AUA guideline. J Urol (2012) 1.27
Determinants of prevalent HIV infection and late HIV diagnosis among young women with two or more sexual partners in Beira, Mozambique. PLoS One (2013) 1.27
Nomograms to predict patency after microsurgical vasectomy reversal. J Urol (2011) 1.26
Factors associated with the safety of voluntary medical male circumcision in Nyanza province, Kenya. Bull World Health Organ (2012) 1.25
Robotic microsurgical vasovasostomy and vasoepididymostomy: a prospective randomized study in a rat model. J Urol (2004) 1.24
Determinants of consistent condom use vary by partner type among young men in Kisumu, Kenya: a multi-level data analysis. AIDS Behav (2008) 1.24
Male circumcision for HIV prevention: current research and programmatic issues. AIDS (2010) 1.24
Safety of over twelve hundred infant male circumcisions using the Mogen clamp in Kenya. PLoS One (2012) 1.24
Vasectomy effectiveness in Nepal: a retrospective study. Contraception (2003) 1.23
Effectiveness of vasectomy using cautery. BMC Urol (2004) 1.19
Prevalence and risk factors of human papillomavirus infection by penile site in uncircumcised Kenyan men. Int J Cancer (2010) 1.17
Incidence and postoperative outcomes of accidental ligation of the testicular artery during microsurgical varicocelectomy. J Urol (2005) 1.17
Comparing direct costs of facility-based Shang Ring provision versus a standard surgical technique for voluntary medical male circumcision in Zambia. J Acquir Immune Defic Syndr (2013) 1.15
The functional and structural consequences of cavernous nerve injury are ameliorated by sildenafil citrate. J Sex Med (2008) 1.15
Alternate indications for varicocele repair: non-obstructive azoospermia, pain, androgen deficiency and progressive testicular dysfunction. Fertil Steril (2011) 1.14
[Male circumcision is an effective "surgical vaccine" for HIV prevention and reproductive health]. Zhonghua Nan Ke Xue (2009) 1.14
Results of vasovasostomy or vasoepididymostomy after failed percutaneous epididymal sperm aspirations. J Urol (2008) 1.13
Abundant expression of HIV target cells and C-type lectin receptors in the foreskin tissue of young Kenyan men. Am J Pathol (2010) 1.13
Resolution of massive uremic tumoral calcinosis with daily nocturnal home hemodialysis. Am J Kidney Dis (2003) 1.12
Cryopreservation of sperm: indications, methods and results. J Urol (2003) 1.12
Functional sequelae of cavernous nerve injury in the rat: is there model dependency. J Sex Med (2006) 1.11
The science of being a study participant: FEM-PrEP participants' explanations for overreporting adherence to the study pills and for the whereabouts of unused pills. J Acquir Immune Defic Syndr (2015) 1.10
Impact of distal ureter management on oncologic outcomes following radical nephroureterectomy for upper tract urothelial carcinoma. Eur Urol (2012) 1.10
Field study of adult male circumcision using the ShangRing in routine clinical settings in Kenya and Zambia. J Acquir Immune Defic Syndr (2014) 1.07